CMPX

CMPX R&D Expenses

$59.45MTTM · USD

Period ending:

CMPX FY R&D ExpensesUSD
CMPX FY R&D Expenses2019-03-31: $27.10M2020-03-31: $22.45M2020-12-31: $14.90M2021-12-31: $20.34M2022-12-31: $30.00M2023-12-31: $38.12M2024-12-31: $42.34M2025-12-31: $55.97M$55.97M$0.00
2019-03-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CMPX r&d expenses history

Research and development spending. The available annual fiscal periods series contains 8 observations from Mar 31, 2019 to Dec 31, 2025.

Compass Therapeutics R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
55,969,000
42,342,000
38,120,000
29,997,000
20,337,000
14,904,000
22,449,000
27,095,000

Compare r&d expenses

All CMPX financial metrics · CMPX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.